Skip to main content

La Jolla Pharmaceutical Co

LJPCDelisted Aug 22, 2022
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000920465

La Jolla Pharmaceutical Co was delisted on Aug 22, 2022; its insiders filed their last Form 4 on Aug 24, 2022; 41 institutions reported holding it in 13F filings for Q2 2022, worth $53.9M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by La Jolla Pharmaceutical Co insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for La Jolla Pharmaceutical Co, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for La Jolla Pharmaceutical Co
NameTitleLast reported holdingLast filingFilings, past year
Tang Kevin CDirector, 10% Owner0IndirectAug 24, 20220
Tang Capital Partners LP10% Owner0IndirectAug 24, 20220
Tang Capital Management LLC10% Owner0IndirectAug 24, 20220
Hearne Michael SChief Financial Officer0IndirectAug 24, 20220
Ramsay David ADirector0Aug 24, 20220
Johnson Craig ADirector0Aug 24, 20220
Rosen RobertDirector–Aug 24, 20220
Johnson Laura L.Director0Aug 24, 20220
Edwards Larry G.Chief Executive Officer0Aug 24, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 6, 2021 (view filing)Dec 2-64 daysRamsay David ADirectorPPurchase+24.5K$3.75+$92.0K+32.5%100.0K after18 lots
Dec 1, 2021 (view filing)7:07 PM ETNov 29-Dec 12 daysTang Kevin C and 3 othersDirector, 10% OwnerSSale−441.3K$3.93−$1.73M−4.4%9.61M after5 lots
Nov 19, 2021 (view filing)Nov 172 daysRamsay David ADirectorPPurchase+7.50K$4.23+$31.7K+11.0%75.5K after